Prosecution Insights
Prosecution Insights
10 pending office actions • 7 art units • 10 examiners • 0 of 10 (0%) have an AI response strategy ready • 11 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (10%) |
| Double-patenting only | 1 (10%) |
| Double-patenting + other | 3 (30%) |
| Multi-statute (no §101) | 4 (40%) |
| No statute on record | 1 (10%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BAKSHI, PANCHAM | 1 | 77.0% | +30.2% |
| DACE DENITO, ALEXANDRA GERALDINE | 1 | 58.9% | +34.1% |
| WILSON, MICHAEL C | 1 | 41.4% | +17.5% |
| ZARA, JANE J | 1 | 70.8% | +16.1% |
| VANHORN, ABIGAIL LOUISE | 1 | 47.0% | +22.0% |
| LAU, JONATHAN S | 1 | 64.0% | -18.2% |
| O'NEILL, MARISOL ANN | 1 | 53.3% | +66.7% |
| CRAIGO, BAHAR ALAWI | 1 | 46.8% | +27.2% |
| MCKILLOP, JOHN CHARLES | 1 | 56.3% | +40.7% |
| TRAN, CHRISTINA L | 1 | 48.2% | +45.5% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18022509 | CELLS AND NON-HUMAN ANIMALS ENGINEERED TO EXPRESS ADAR1 AND USES THEREOF | WILSON, MICHAEL C | 8d overdue |
| 17426511 | OLIGONUCLEOTIDE COMPOSITIONS AND METHODS THEREOF | TRAN, CHRISTINA L | 14d |
| 17926987 | OLIGONUCLEOTIDE COMPOSITIONS AND METHODS THEREOF | LAU, JONATHAN S | — |
| 17953292 | OLIGONUCLEOTIDE COMPOSITIONS AND METHODS THEREOF | O'NEILL, MARISOL ANN | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18022509 | CELLS AND NON-HUMAN ANIMALS ENGINEERED TO EXPRESS ADAR1 AND USES THEREOF | WILSON, MICHAEL C | 8d overdue |
| 18313032 | CHIRAL CONTROL | BAKSHI, PANCHAM | 3d overdue |
| 17426511 | OLIGONUCLEOTIDE COMPOSITIONS AND METHODS THEREOF | TRAN, CHRISTINA L | 14d |
| 18178470 | OLIGONUCLEOTIDE COMPOSITIONS AND METHODS OF USE THEREOF | DACE DENITO, ALEXANDRA GERALDINE | — |
| 18072296 | METHODS AND COMPOSITIONS OF BIOLOGICALLY ACTIVE AGENTS | ZARA, JANE J | — |
| 17926967 | DOUBLE STRANDED OLIGONUCLEOTIDE COMPOSITIONS AND METHODS RELATING THERETO | VANHORN, ABIGAIL LOUISE | — |
| 17953292 | OLIGONUCLEOTIDE COMPOSITIONS AND METHODS THEREOF | O'NEILL, MARISOL ANN | — |
| 17881956 | COMPOSITIONS AND METHODS FOR PHOSPHORAMIDITE AND OLIGONUCLEOTIDE SYNTHESIS | CRAIGO, BAHAR ALAWI | — |
| Art Unit | Apps |
|---|---|
| 1637 | 3 |
| 1636 | 2 |
| 1623 | 1 |
| 1638 | 1 |
| 1693 | 1 |
| 1633 | 1 |
| 1699 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18313032 | CHIRAL CONTROL | BAKSHI, PANCHAM | 1623 | Other | Non-Final OA | 3d overdue | Pending | May 05, 2023 |
| 18178470 | OLIGONUCLEOTIDE COMPOSITIONS AND METHODS OF USE THEREOF | DACE DENITO, ALEXANDRA GERALDINE | 1636 | §103§112DP | Non-Final OA | — | Pending | Mar 03, 2023 |
| 18022509 | CELLS AND NON-HUMAN ANIMALS ENGINEERED TO EXPRESS ADAR1 AND USES THEREOF | WILSON, MICHAEL C | 1638 | §103§112 | Non-Final OA | 8d overdue | Pending | Feb 21, 2023 |
| 18072296 | METHODS AND COMPOSITIONS OF BIOLOGICALLY ACTIVE AGENTS | ZARA, JANE J | 1637 | DP | Non-Final OA | — | Pending | Nov 30, 2022 |
| 17926967 | DOUBLE STRANDED OLIGONUCLEOTIDE COMPOSITIONS AND METHODS RELATING THERETO | VANHORN, ABIGAIL LOUISE | 1636 | §103§112DP | Non-Final OA | — | Pending | Nov 21, 2022 |
| 17926987 | OLIGONUCLEOTIDE COMPOSITIONS AND METHODS THEREOF | LAU, JONATHAN S | 1693 | §103§112 | Non-Final OA | — | Pending | Nov 21, 2022 |
| 17953292 | OLIGONUCLEOTIDE COMPOSITIONS AND METHODS THEREOF | O'NEILL, MARISOL ANN | 1633 | §103§112 | Non-Final OA | — | Pending | Sep 26, 2022 |
| 17881956 | COMPOSITIONS AND METHODS FOR PHOSPHORAMIDITE AND OLIGONUCLEOTIDE SYNTHESIS | CRAIGO, BAHAR ALAWI | 1699 | §103 | Final Rejection | — | Pending | Aug 05, 2022 |
| 17766677 | OLIGONUCLEOTIDE COMPOSITIONS AND METHODS OF USE THEREOF | MCKILLOP, JOHN CHARLES | 1637 | §102§103DP | Final Rejection | — | Pending | Apr 05, 2022 |
| 17426511 | OLIGONUCLEOTIDE COMPOSITIONS AND METHODS THEREOF | TRAN, CHRISTINA L | 1637 | §103§112 | Non-Final OA | 14d | Pending | Jul 28, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial